2020
Differences in maternal group B Streptococcus screening rates in Latin American countries
HogenEsch E, De Mucio B, Haddad LB, Vilajeliu A, Ropero AM, Yildirim I, Omer SB. Differences in maternal group B Streptococcus screening rates in Latin American countries. Vaccine 2020, 39: b3-b11. PMID: 33308886, DOI: 10.1016/j.vaccine.2020.10.082.Peer-Reviewed Original ResearchConceptsMaternal GBS screeningMaternal GBS colonizationGBS screeningGBS colonizationScreening ratesPregnant womenGroup B Streptococcus ScreeningMaternal group B StreptococcusLogistic regressionGBS colonization prevalenceIntrapartum antibiotic treatmentMaternal GBS vaccineNeonatal GBS diseaseAdverse neonatal outcomesRetrospective observational studyMaternal age groupsGroup B streptococciDemographic variablesLower ratesGBS prevalenceFinal regression modelGBS diseaseNeonatal outcomesNeonatal sepsisGBS vaccine
2019
3162 Colonization of Pregnant Women with Group B streptococcus in Latin America and Infant Outcomes
HogenEsch E, Haddad L, Yildirim I, Omer S. 3162 Colonization of Pregnant Women with Group B streptococcus in Latin America and Infant Outcomes. Journal Of Clinical And Translational Science 2019, 3: 37-38. PMCID: PMC6808231, DOI: 10.1017/cts.2019.92.Peer-Reviewed Original ResearchMaternal GBS colonizationGBS colonizationPreterm birthCesarean sectionPregnant womenRisk factorsGBS diseasePerinatal outcomesMaternal colonizationPrevalence ratesExact testSignificant associationMultiple logistic regression modelBurden of stillbirthsGBS colonization statusGBS-negative mothersGBS-positive mothersMaternal GBS carriageNeonatal GBS diseasePerinatal health indicatorsSpecific perinatal outcomesIncidence of sepsisClinical risk factorsWeeks of gestationGroup B streptococci
2010
Interpretation of 2002 Centers for Disease Control Guidelines for Group B Streptococcus and Evolving Provider Practice Patterns
Barber E, Funai E, Bracken M, Illuzzi J. Interpretation of 2002 Centers for Disease Control Guidelines for Group B Streptococcus and Evolving Provider Practice Patterns. American Journal Of Perinatology 2010, 28: 097-102. PMID: 20640975, PMCID: PMC3224803, DOI: 10.1055/s-0030-1262907.Peer-Reviewed Original ResearchMeSH KeywordsAntibiotic ProphylaxisCarrier StateFemaleGuideline AdherenceHumansInfant, NewbornInfectious Disease Transmission, VerticalLabor, ObstetricMaleMidwiferyPhysiciansPractice Guidelines as TopicPractice Patterns, Physicians'PregnancyPregnancy Complications, InfectiousStreptococcal InfectionsStreptococcus agalactiaeConceptsDisease Control guidelinesGroup B streptococciManagement of labourCDC guidelinesB streptococciControl guidelinesHours of prophylaxisPerinatal GBS diseaseIntrapartum antibiotic prophylaxisProvider practice patternsAntibiotic prophylaxisIntrapartum prophylaxisGBS diseasePositive womenArtificial ruptureOxytocin infusionPractice patternsEligible cliniciansLabor floorClinical settingProphylaxisCliniciansClinical applicationStreptococciGuidelines
2006
Duration of Intrapartum Prophylaxis for Neonatal Group B Streptococcal Disease
Illuzzi JL, Bracken MB. Duration of Intrapartum Prophylaxis for Neonatal Group B Streptococcal Disease. Obstetrics And Gynecology 2006, 108: 1254-1265. PMID: 17077253, DOI: 10.1097/01.aog.0000241539.86451.11.Peer-Reviewed Original ResearchConceptsIntrapartum antibiotic prophylaxisGroup B streptococciTransmission of GBSHours of prophylaxisIntrapartum prophylaxisAntibiotic prophylaxisGBS diseaseAmerican CollegeNeonatal group B streptococcal diseaseEarly-onset GBS sepsisEarly-onset GBS diseaseGroup B streptococcal diseaseStudy designNeonatal GBS colonizationCochrane Central RegisterProspective cohort studyCase-control studyGBS sepsisGynecologists guidelinesInfant colonizationCentral RegisterCohort studyControlled TrialsCase seriesHistorical cohort
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply